NCT00627393 · OUTCOME
Overall Incidence of Adverse Effects
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- Measured through Day 42
Analysis population: All randomized subjects.
Groups in this outcome
Control Arm
Received antimicrobial therapy alone.
Granulocyte Arm
Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.
| Group | Source count |
|---|---|
| Control Arm | 58 |
| Granulocyte Arm | 56 |
Reported measurements
0 Event
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control Arm | 33 | Not reported | Not reported | Not reported | Not reported |
| Granulocyte Arm | 30 | Not reported | Not reported | Not reported | Not reported |
1 Event
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control Arm | 21 | Not reported | Not reported | Not reported | Not reported |
| Granulocyte Arm | 20 | Not reported | Not reported | Not reported | Not reported |
2 Events
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control Arm | 2 | Not reported | Not reported | Not reported | Not reported |
| Granulocyte Arm | 5 | Not reported | Not reported | Not reported | Not reported |
3 Events
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control Arm | 1 | Not reported | Not reported | Not reported | Not reported |
| Granulocyte Arm | 0 | Not reported | Not reported | Not reported | Not reported |
6 Events
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control Arm | 0 | Not reported | Not reported | Not reported | Not reported |
| Granulocyte Arm | 1 | Not reported | Not reported | Not reported | Not reported |
9 Events
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Control Arm | 1 | Not reported | Not reported | Not reported | Not reported |
| Granulocyte Arm | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 33
- group Id
- OG001
- value
- 30
- title
- 0 Event
- categories
- measurements
- group Id
- OG000
- value
- 21
- group Id
- OG001
- value
- 20
- title
- 1 Event
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 5
- title
- 2 Events
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 0
- title
- 3 Events
- categories
- measurements
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 1
- title
- 6 Events
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 0
- title
- 9 Events
- denoms
- counts
- group Id
- OG000
- value
- 58
- group Id
- OG001
- value
- 56
- units
- Participants
- groups
- description
- Received antimicrobial therapy alone.
- id
- OG000
- title
- Control Arm
- description
- Received G-CSF/dexamethasone-mobilized granulocyte transfusions in addition to antimicrobial therapy.
- id
- OG001
- title
- Granulocyte Arm
- param Type
- NUMBER
- population Description
- All randomized subjects.
- reporting Status
- POSTED
- time Frame
- Measured through Day 42
- title
- Overall Incidence of Adverse Effects
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle